Bioavailability study of oral and intravenous OGT 719, a novel nucleoside analogue with preferential activity in the liver.


Autoria(s): Eatock, Martin
Data(s)

2001

Identificador

http://pure.qub.ac.uk/portal/en/publications/bioavailability-study-of-oral-and-intravenous-ogt-719-a-novel-nucleoside-analogue-with-preferential-activity-in-the-liver(7f644aee-f57e-4e06-8aca-14fc7b00d8c0).html

http://www.scopus.com/inward/record.url?scp=17944369127&partnerID=8YFLogxK

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Eatock , M 2001 , ' Bioavailability study of oral and intravenous OGT 719, a novel nucleoside analogue with preferential activity in the liver. ' Cancer Chemotherapy and Pharmacology , vol 48(3) , no. 3 , pp. 197-201 .

Palavras-Chave #/dk/atira/pure/subjectarea/asjc/1300/1306 #Cancer Research #/dk/atira/pure/subjectarea/asjc/3000/3004 #Pharmacology #/dk/atira/pure/subjectarea/asjc/2700/2730 #Oncology
Tipo

article